Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01441674 · ClinicalTrials.gov registry record · Phase 1

Animal Assisted Therapy in a Pediatric Setting

A Phase 1 study, sponsored by Children's Hospitals and Clinics of Minnesota.

Completed
Registry status
Phase 1
Development phase
30
Enrollment target

NCT01441674: Completed Phase 1 study, sponsored by Children's Hospitals and Clinics of Minnesota.

NCT01441674 is a Phase 1 study that has completed, run by Children's Hospitals and Clinics of Minnesota. The registered enrollment target is 30 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (50% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01441674, a Phase 1 study, has completed, sponsored by Children's Hospitals and Clinics of Minnesota.

COMPLETED
Registry status
Phase 1
Development phase
30 participants
Enrollment target

Study Summary

The primary purpose for this study is to determine if children who receive Occupational Therapy while they are an inpatient in the hospital will be more motivated to participate in therapy as well as increase the amount of time they will work during that particular session when a therapy dog is present during their sessions. The investigators will also be collecting data regarding a child's heart rate and blood pressure prior to the session starting and ending to determine if having a therapy dog present also helps relax a child.

Primary Outcome

The patients response to therapy can be measures using the following behavior domains (cognition, fine motor, activities and daily living, feeding skills, active range of motion/activities, and functional Transfers).

Interventions

  • BEHAVIORAL Animal Assisted Therapy

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2011-01
Est. Completion 2013-12
Phase Phase 1

What the finished NCT01441674 record still lists

NCT01441674 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (50% lower).

The record links to 0 conditions, and to 1 intervention - of which Animal Assisted Therapy is the first listed.

NCT01441674 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01441674 about?

NCT01441674 is a clinical study titled "Animal Assisted Therapy in a Pediatric Setting". The primary purpose for this study is to determine if children who receive Occupational Therapy while they are an inpatient in the hospital will be more motivated to participate in therapy as well as increase the amount of time they will work during that particular session when a therapy dog is pres...

What is the current status of trial NCT01441674?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 30 participants. The study started on 2011-01. Estimated completion is 2013-12.

What interventions are being tested in trial NCT01441674?

The interventions under investigation include: Animal Assisted Therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT01441674?

This trial is sponsored by Children's Hospitals and Clinics of Minnesota, which has 31 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01441674's enrollment target sits among peer trials

30 1332nd of 2000 higher than 561 of 2,000 other Phase 1 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01441674, the US trial registry maintained by the National Library of Medicine. NCT01441674 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.